| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.24▼ | 3.26▼ | 3.26▼ | 3.17▲ | 3.25▼ |
| MA10 | 3.25▼ | 3.26▼ | 3.24▼ | 3.17▲ | 3.30▼ |
| MA20 | 3.25▼ | 3.23▼ | 3.23▼ | 3.25▼ | 3.31▼ |
| MA50 | 3.26▼ | 3.19▲ | 3.18▲ | 3.30▼ | 3.52▼ |
| MA100 | 3.25▼ | 3.18▲ | 3.16▲ | 3.34▼ | 2.92▲ |
| MA200 | 3.24▼ | 3.18▲ | 3.26▼ | 3.60▼ | 2.91▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | -0.003▼ | 0.002▲ | 0.004▲ | -0.016▼ |
| RSI | 35.346▼ | 50.000▼ | 52.700▲ | 50.101▲ | 45.720▼ |
| STOCH | 18.333▼ | 39.573 | 66.682 | 66.525 | 46.986 |
| WILL %R | -80.000▼ | -60.714 | -45.946 | -35.542 | -46.231 |
| CCI | -123.087▼ | -83.965 | 24.254 | 60.967 | -70.091 |
|
Tuesday, April 22, 2025 11:01 PM
Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage ...
|
|
Thursday, April 17, 2025 08:59 AM
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline ...
|
|
Tuesday, April 01, 2025 03:45 AM
In this article, we are going to take a look at where Arbutus Biopharma Corporation (NASDAQ:ABUS) stands against the other stocks featured in Jim Cramer's Lightning Round. Jim Cramer, the host of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/04/25 | 3.27 | 3.32 | 3.22 | 3.24 | 544,026 |
| 22/04/25 | 3.25 | 3.27 | 3.135 | 3.19 | 652,932 |
| 21/04/25 | 3.10 | 3.32 | 3.085 | 3.21 | 1,014,526 |
| 17/04/25 | 3.05 | 3.16 | 3.00 | 3.15 | 744,826 |
| 16/04/25 | 3.15 | 3.17 | 2.995 | 3.06 | 1,123,210 |
| 15/04/25 | 3.27 | 3.34 | 3.15 | 3.16 | 1,054,353 |
| 14/04/25 | 3.18 | 3.31 | 3.15 | 3.28 | 1,245,043 |
| 11/04/25 | 3.12 | 3.19 | 3.04 | 3.14 | 912,062 |
| 10/04/25 | 3.09 | 3.135 | 3.00 | 3.12 | 1,482,693 |
| 09/04/25 | 2.85 | 3.225 | 2.705 | 3.17 | 2,695,729 |
|
|
||||
|
|
||||
|
|